Cargando…
Synergic silencing of costimulatory molecules prevents cardiac allograft rejection
BACKGROUND: While substantial progress has been made in blocking acute transplant rejection with the advent of immune suppressive drugs, chronic rejection, mediated primarily by recipient antigen presentation, remains a formidable problem in clinical transplantation. We hypothesized that blocking co...
Autores principales: | Zhang, Xusheng, Liu, Yanling, Zhang, Guangfeng, Shi, Jun, Zhang, Xiao, Zheng, Xiufen, Jiang, Alex T, Zhang, Zhu-Xu, Johnston, Nathan, Siu, King Sun, Chen, Ruiqi, Lian, Dameng, Koos, David, Quan, Douglas, Min, Wei-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040111/ https://www.ncbi.nlm.nih.gov/pubmed/24886282 http://dx.doi.org/10.1186/1479-5876-12-142 |
Ejemplares similares
-
Prevention of allograft rejection in heart transplantation through concurrent gene silencing of TLR and Kinase signaling pathways
por: Wang, Hongmei, et al.
Publicado: (2016) -
Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection
por: Rosado-Sánchez, Isaac, et al.
Publicado: (2023) -
Association of Polymorphisms in T-Cell Activation Costimulatory/Inhibitory Signal Genes With Allograft Kidney Rejection Risk
por: Santiago, Jose Luis, et al.
Publicado: (2021) -
Correction: Thalidomide with blockade of costimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts
por: Zhu, Maoshu, et al.
Publicado: (2022) -
Neuroimmune semaphorins as costimulatory molecules and beyond
por: Chapoval, Svetlana P.
Publicado: (2018)